Prostate formula
Prostate formula, licence 80068860: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80068860
- Status
- Active licence
- Licence date
- 26 April 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Juniperus communis Source : Juniperus communis - Fruit | 37.5 milligramme | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 125.0 milligramme | 25.0 milligramme | Not calculated |
| Serenoa repens Source : Serenoa repens - fruit Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 160.0 milligramme | 40.0 milligramme | Not calculated |
| Prunus africana Source : Écorce (branche) Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 50.0 milligramme | 5.0 milligramme | Not calculated |
| Lycopène tout trans Source : Solanum lycopersicum - fruit | 2.5 milligramme | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 750.0 milligramme | 75.0 milligramme | Not calculated |
| Lécithine Source : Lecithin | 50.0 milligramme | Not calculated |
| Vitamine B6 Source : Vitamine B6 | 7.5 milligramme | 30,000 µg |
| Acide 2-hydroxy-1,2,3-propanetricarboxylique, sel de zinc, hydraté (2:3:3) Source : Citrate de zinc trihydrate | 5.0 milligramme | Not calculated |
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 187.5 milligramme | 37.5 milligramme | Not calculated |
| Vaccinium macrocarpon Source : Vaccinium macrocarpon- fruit | 37.5 milligramme | Not calculated |
| Eucommia ulmoides Source : Tige(s) Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 125.0 milligramme | 25.0 milligramme | Not calculated |
| Cucurbita moschata Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 250.0 milligramme | 25.0 milligramme | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH). Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps to support prostate health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80068860
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.